1Atherton DS,Deep NL, Mendelsohn FO. Micro-anatomy of the renal sympathetic ner','ous system : a human postmortem hlstologic study. Clin Anat, 2012, 25: 628-633.
2Davis MI,Filion KB, Zhang D, et al. Effectiveness of renal denervation therapy for resistant hypertension : a systematic review and meta-analysis. J Am Coll Cardiol, 2013, 62: 231-241.
7Calhoun DA,Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [ J ]. Circulation, 2008, 117: e510-e526.
8Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) [ J ]. JAMA, 2003, 289: 2560-2572.
9Bangalore S, Fayyad R, Laskey R, et al. Prevalence, predictors, and outcomes in treatment resistant hypertension in patients with coronary disease[ J]. Am J Med, 2014, 127 : 71-81.
10Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension[ Jl. Am J Hypertens, 2003, 16: 925-930.
